For the past week, Beauchamp v New York City Transit Authority has been the New York damages case everyone is talking about, and understandably so. The First Department approved what it described as perhaps one of the largest personal-injury awards ever sustained by an Appellate Division.
At a Glance
Summary: The First Department reduced a $72.5 million verdict but permitted the plaintiffs to recover nearly $48 million for catastrophic injuries, future medical expenses, and loss of services.
Case: Beauchamp v New York City Transit Authority, 2026 NY Slip Op 05364 (1st Dept Sept. 17, 2026)
Court: Appellate Division, First Department
Injuries Described: Complete lumbosacral-plexus avulsion; virtual paralysis and loss of sensation in one leg; pelvic and 19 rib fractures; ruptured bladder and permanent incontinence; extensive crush and degloving injuries; chronic infections; complex regional pain syndrome; PTSD; and suicidal ideation.
Jury Award Challenged: $72.5 million, consisting of $25 million for past pain and suffering, $32 million for future pain and suffering, $8.5 million for future medical expenses, $3 million for past loss of services, and $4 million for future loss of services.
Challenge: The defendants argued that the pain-and-suffering and loss-of-services awards were excessive and that part of the future-medical award lacked the required evidentiary support.
Result: A new damages trial unless the plaintiffs stipulate to a total recovery of $47,838,345.
The Accident and Catastrophic Injury Record
Aurora Beauchamp was 62 years old when she was struck by a New York City Transit Authority bus while walking in a Manhattan crosswalk. The bus was making a left turn and traveling approximately eight miles per hour.
The impact pulled her underneath the bus. She was dragged and then pinned beneath a tire for approximately 20 minutes. She remained conscious and believed she was going to die while first responders worked to lift the bus and free her.
Her injuries were extraordinary. They included a complete lumbosacral-plexus avulsion, numerous pelvic fractures, 19 fractured ribs, a ruptured bladder, and severe crush and degloving injuries.
During emergency pelvic-reconstruction surgery, Beauchamp lost approximately four liters of blood—about 80% of her total blood volume. Surgeons had to abort the procedure, and she was placed in a medically induced coma while physicians addressed multiple life-threatening conditions.
She remained hospitalized for 43 days and then spent another 112 days in rehabilitation and nursing facilities. Her degloving wound never healed and continued to cause recurrent infections and hospitalizations.
The accident left one leg virtually paralyzed and without sensation. Beauchamp developed complex regional pain syndrome and described persistent pain at a level of eight or nine out of ten. Ordinary activities such as being turned in bed, cleaned, or helped into a chair intensified that pain.
She also remained incontinent, experienced nightmares and flashbacks, and received treatment for PTSD and suicidal ideation. Her physicians considered a spinal-cord stimulator and total hip replacement, but the continuing infection risk made those procedures inadvisable.
Her husband became her principal caregiver. The couple left their inaccessible two-story home and moved into a relative’s one-level condominium.
The $72.5 Million Verdict
The defendants conceded liability, leaving damages and loss of services for trial.
The jury awarded:
- $25 million for past pain and suffering;
- $32 million for future pain and suffering;
- $8.5 million for future medical expenses;
- $3 million for past loss of services; and
- $4 million for future loss of services.
The total award was $72.5 million.
The First Department’s Reduction
Applying CPLR 5501(c), the First Department concluded that several components materially deviated from reasonable compensation.
The court ordered a new trial unless the plaintiffs stipulated to reduce:
- Past pain and suffering from $25 million to $20 million;
- Future pain and suffering from $32 million to $17 million;
- Past loss of services from $3 million to $1.5 million; and
- Future loss of services from $4 million to $1.1 million.
The court also reduced future medical expenses from $8.5 million to $8,238,345. That was the amount calculated by the plaintiffs’ experts and requested by counsel during summation.
The proposed spinal-cord stimulator and hip replacement could not justify the additional amount because the medical testimony established that those procedures were inadvisable and might never be performed.
The resulting permissible recovery is $47,838,345.
Why Nearly $48 Million Survived Appellate Review
The First Department acknowledged that the reduced award remained substantial and might be among the largest personal-injury recoveries ever approved by an Appellate Division. It nevertheless concluded that the amount was not manifestly excessive given the “extraordinary injuries” involved.
The court distinguished the defendants’ comparators because those plaintiffs eventually walked or lived independently. Beauchamp might never walk without assistance and could not realistically aspire to independent living.
That distinction is critical. A damages comparison cannot stop with diagnoses, surgeries, or dollar amounts. The comparison must address:
- Functional independence;
- Ability to walk and perform daily activities;
- Frequency and intensity of pain;
- Whether treatment can improve the condition;
- Risk of future deterioration;
- Psychological consequences;
- Continuing hospitalization and infection;
- Dependence on a spouse or caregiver; and
- The interaction among multiple permanent injuries.
The Court also observed that the defendants had not cited a New York case involving comparable injuries in which a lower award had been sustained.
That is an important appellate lesson. A remittitur argument is only as strong as its comparators. Citing lower awards involving substantially better recoveries or functional outcomes may reinforce why the challenged plaintiff falls outside the ordinary range.
Claims and Litigation Lesson: Large Verdicts Must Be Managed Before Trial
Beauchamp is not merely a warning about catastrophic verdicts. It is a roadmap for identifying, quantifying, and managing high-severity exposure long before the jury begins deliberating.
1. Assess catastrophic exposure early
A high-value file should receive a coordinated liability, medical, economic, and appellate assessment as soon as the potential severity becomes apparent.
Do not wait until expert disclosure or mediation. Early evaluation affects reserves, discovery, surveillance, expert selection, settlement authority, and trial strategy.
2. Begin the medical-record review immediately
Create a complete chronology addressing:
- Preexisting conditions;
- Objective diagnostic findings;
- Surgeries and complications;
- Treatment gaps;
- Medication history;
- Functional restrictions;
- Activities of daily living;
- Psychological treatment;
- Future treatment recommendations; and
- Whether proposed procedures are medically feasible.
The future-medical reduction in Beauchamp shows why every treatment must be supported by testimony establishing that it is reasonably certain to occur. A procedure that might help—but is too dangerous to perform—should not become part of the recoverable life-care plan.
3. Identify sustainable Appellate Division values
Evaluate the claim against awards the controlling Appellate Division has actually sustained for genuinely comparable injuries.
Compare function, treatment, permanence, age, independence, work capacity, psychological consequences, and future medical needs—not merely the injured body parts.
That analysis should begin before mediation and should be updated before trial, after the verdict, and during any CPLR 4404(a) motion.
4. Retain both an economist and an actuary
A forensic economist can test lost-earnings assumptions, inflation, work-life expectancy, medical-cost growth, and present value.
An actuary or qualified structured-settlement professional can calculate what the future-payment stream will actually cost to fund.
Those are different questions. A $20 million nominal future award does not necessarily require $20 million in present cash. Claims professionals should know both the verdict’s nominal value and the actual cost of satisfying or settling it.
5. Develop the collateral-source proof before the verdict
CPLR 4545 permits a post-verdict reduction when an economic loss will, with reasonable certainty, be replaced by an eligible collateral source.
In Liciaga v New York City Transit Authority, the Second Department held that evidence of insurance available through the Affordable Care Act could justify a collateral-source hearing concerning future medical expenses.
But a generalized reference to the ACA is not enough. In Sinera v Bedford-Webster LLC, the First Department held that possession of a Social Security number did not establish eligibility for a specific plan, enrollment, or the extent of coverage.
The defense should develop competent evidence concerning:
- Eligibility for a particular plan;
- Covered treatments and providers;
- Premiums, deductibles, and copayments;
- Policy exclusions and coverage limits;
- Continued availability of coverage;
- Liens or reimbursement rights; and
- Direct correspondence between the covered benefit and the economic loss awarded.
That work should begin during discovery—not after the verdict.
6. Run an Article 50-B analysis before mediation and trial
For qualifying personal-injury judgments, CPLR Article 50-B changes how future damages exceeding $250,000 are paid.
Past damages and the first $250,000 of future damages are generally paid in a lump sum. The remaining future damages are funded through periodic payments under CPLR 5041.
Before making a settlement recommendation, calculate:
- The nominal verdict exposure;
- The projected Article 50-B judgment;
- The present value of the required annuity;
- The cost of purchasing that annuity;
- The effect of the statutory payment periods;
- The effect of payments terminating upon the plaintiff’s death; and
- The difference between a cash settlement and a structured resolution.
That comparison may reveal substantial funding savings that are invisible when everyone focuses only on the headline verdict.
7. Insist on the correct Article 50-B attorney-fee calculation
Plaintiff’s counsel does not automatically receive one-third of the nominal future-damages award.
Under CPLR 5041(c) and Rohring v City of Niagara Falls, the attorney’s fee attributable to periodically paid future damages is calculated from the present value of the annuity contract, not simply from the face amount of the future-damages verdict.
Where the verdict’s duration is based on the plaintiff’s life expectancy, that period affects the present-value calculation. For pain and suffering, however, CPLR 5041(e) uses ten years or the period found by the jury, whichever is shorter.
The argument is therefore not merely that the fee is “based on life expectancy.” It is that the fee must be calculated from the present value of the statutorily required payment stream rather than by taking one-third of the nominal total.
Because Bryant v New York City Health & Hospitals Corp. requires the statutory 4% additur to be incorporated into the calculation, this analysis should be performed by someone who regularly prepares Article 50-B judgments.
8. Compare Article 50-B with a negotiated structure
Article 50-B does not prevent the parties from negotiating a different settlement structure. CPLR 5047 expressly preserves their discretion to settle on mutually acceptable terms.
A voluntary structure may combine:
- Immediate cash;
- Guaranteed periodic payments;
- Life-contingent payments;
- Deferred lump sums;
- Annuity-funded medical expenses; and
- Other terms tailored to the plaintiff’s actual needs.
Obtain qualified structure quotes and compare the cost with the projected Article 50-B judgment. The right structure may provide the plaintiff with secure long-term benefits while materially reducing the defendant’s present funding cost.
The key is to perform that analysis while meaningful settlement opportunities still exist—not after a catastrophic verdict has eliminated most of the leverage.
More Verdict Value Day Posts
- Verdict Value Day: $13 Million for Pain and Suffering Survives in Labor Law § 240(1) Fall
- Verdict Value Day: Second Department Cuts TBI Award from $4.93 Million to $1.75 Million
- Browse every Verdict Value Day analysis
Photo Credit: Angelica Teran